UK-based AstraZeneca (AZ; NASDAQ: AZN) has launched Evinova, a digital health solutions provider, with the aim of supporting global clinical development. Evinova offers AI-enabled technologies and services to clinical trial (CT) sponsors, clinical research organizations (CROs), CT site care teams, and patients. The new business unit will initially focus on optimizing CT design and delivery, while also developing future innovations in remote patient monitoring and digital therapeutics.
Evinova’s Partnerships and Collaborations
Evinova has already secured agreements to provide its solutions to CROs Parexel and Fortrea (NASDAQ: FTRE). Additionally, it is collaborating with Accenture (NYSE: ACN) and Amazon Web Services (NASDAQ: AMZN) to accelerate the adoption of its products, indicating a strong start for the new unit in the digital health space.- Flcube.com
